Formulation for Type 2 Diabetes Mellitus

Anti-Hyperglycemic Effect of Abhraka prayoga in Type 2 Diabetes Mellitus - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/107770

Enrollment

Registered

2026-04-07

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Participants with HbA1c levels between 6.5% and 8% 2. Participants who have not yet started taking any modern anti-hyperglycemic drugs.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating women 2. Cases diagnosed with cardiovascular disease, or renal/hepatic failure

Design outcomes

Primary

Measure	Time frame
Glycosylated Hemoglobin (HbA1c) to assess average blood glucose levels over the past 2 3 months. Timepoint: HbA1C at 0th and 90 th day.	—

Secondary

Measure	Time frame
1. Fasting Blood Glucose (FBG) measured in mg/dL using standardized laboratory techniques. 2. Post-Prandial Blood Glucose (PPBS) assessed 2 hours after a meal to evaluate postmeal glycemic control. 3. Subjective Symptom Relief: Evaluation of key symptoms associated with Prameha/Type 2 diabetes mellitus such as fatigue (klama), excessive thirst (trishna), and frequent urination (prabhuta mutrata) using a standardized symptom scoring scale. Timepoint: 0th, 30th, 60th and 90th day	—

Measure

Time frame

1. Fasting Blood Glucose (FBG) measured in mg/dL using standardized laboratory techniques. 2. Post-Prandial Blood Glucose (PPBS) assessed 2 hours after a meal to evaluate postmeal glycemic control. 3. Subjective Symptom Relief: Evaluation of key symptoms associated with Prameha/Type 2 diabetes mellitus such as fatigue (klama), excessive thirst (trishna), and frequent urination (prabhuta mutrata) using a standardized symptom scoring scale. Timepoint: 0th, 30th, 60th and 90th day

—

Countries

India

Contacts

Public ContactDr Mohzina Raffi

Government Ayurveda College Thiruvananthapuram Kerala

drtharalekshmi@gmail.com9539757256

Outcome results